C12N 2760/18861
Methods of inactivation or attenuation
C12N2760/18861 (Methods of inactivation or attenuation) appears on 8 US grants and 22 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 22
- Assignees
- 10
- Inventors
- 40
- Latest grant
- 27 Dec 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 4 |
| 2004 | 0 | 2 |
| 2005 | 1 | 2 |
| 2006 | 0 | 0 |
| 2007 | 2 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 3 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 0 | 2 |
| 2016 | 2 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Composition for inactivating an enveloped virus27 Dec 2016US 9,526,700 B2Viroblock S.A.
- Method for inactivating viruses with slightly acidic arginine11 Oct 2016US 9,462,810 B2Ajinomoto Co., Inc.
- Composition for inactivating an enveloped virus18 Nov 2014US 8,889,398 B2Viroblock S.A.
- Method for inactivating viruses with slightly acidic arginine11 Mar 2014US 8,669,045 B2Ajinomoto Co., Inc.
- Virus envelope vector for gene transfer28 Sep 2010US 7,803,621 B2AnGes MG, Inc.
- Improved negative-strand rna viral vector12 Jul 2018US 2018/0195085 A1ID Pharma Co., Ltd.
- Semi-live respiratory syncytial virus vaccine5 May 2016US 2016/0120974 A1Amvac AG
- Method for expression of heterologous proteins using a recombinant negative-strand rna virus vector14 May 2015US 2015/0133531 A1Amvac AG
- Composition for Inactivating an Enveloped Virus5 Mar 2015US 2015/0065458 A1Viroblock S.A.
- Method for Inactivating Viruses With Slightly Acidic Arginine17 Apr 2014US 2014/0107207 A1Ajinomoto Co., Inc.
Most cited
By later US patents
- Virus envelope vector for gene transfer5US 6,913,923 B2AnGes MG, Inc. · 2005
- Envelope gene-deficient Paramyxovirus vector4US 7,226,786 B2DNAVEC Research Inc. · 2007
- Virus envelope vector for gene transfer2US 7,279,333 B2AnGes MG, Inc. · 2007
- Virus envelope vector for gene transfer1US 7,803,621 B2AnGes MG, Inc. · 2010
- Method for inactivating viruses with slightly acidic arginine1US 8,669,045 B2Ajinomoto Co., Inc. · 2014